Your browser doesn't support javascript.
loading
Accessory heterozygous mutations in cone photoreceptor CNGA3 exacerbate CNG channel-associated retinopathy.
Burkard, Markus; Kohl, Susanne; Krätzig, Timm; Tanimoto, Naoyuki; Brennenstuhl, Christina; Bausch, Anne E; Junger, Katrin; Reuter, Peggy; Sothilingam, Vithiyanjali; Beck, Susanne C; Huber, Gesine; Ding, Xi-Qin; Mayer, Anja K; Baumann, Britta; Weisschuh, Nicole; Zobor, Ditta; Hahn, Gesa-Astrid; Kellner, Ulrich; Venturelli, Sascha; Becirovic, Elvir; Charbel Issa, Peter; Koenekoop, Robert K; Rudolph, Günther; Heckenlively, John; Sieving, Paul; Weleber, Richard G; Hamel, Christian; Zong, Xiangang; Biel, Martin; Lukowski, Robert; Seeliger, Matthias W; Michalakis, Stylianos; Wissinger, Bernd; Ruth, Peter.
Affiliation
  • Burkard M; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy.
  • Kohl S; Department of Vegetative and Clinical Physiology.
  • Krätzig T; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
  • Tanimoto N; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy.
  • Brennenstuhl C; Division of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Bausch AE; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy.
  • Junger K; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy.
  • Reuter P; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy.
  • Sothilingam V; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
  • Beck SC; Division of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Huber G; Division of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Ding XQ; Division of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Mayer AK; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Baumann B; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
  • Weisschuh N; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
  • Zobor D; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
  • Hahn GA; Institute of Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Kellner U; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
  • Venturelli S; Rare Retinal Disease Center, Augenzentrum Siegburg, MVZ ADTC Siegburg GmbH, Siegburg, Germany.
  • Becirovic E; Department of Vegetative and Clinical Physiology.
  • Charbel Issa P; Center for Integrated Protein Science Munich CiPSM and Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Koenekoop RK; Oxford Eye Hospital, OUH NHS Foundation Trust and the Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Rudolph G; McGill Ocular Genetics Centre, McGill University Health Centre, Montreal, Quebec, Canada.
  • Heckenlively J; University Eye Hospital Munich, Munich, Germany.
  • Sieving P; Kellogg Eye Center, Ann Arbor, Michigan, USA.
  • Weleber RG; The National Eye Institute, Bethesda, Maryland, USA.
  • Hamel C; Casey Eye Institute, Department of Ophthalmogenetics, Portland, Oregon, USA.
  • Zong X; INSERM U583, Institut des Neurosciences, Montpellier, France.
  • Biel M; Center for Integrated Protein Science Munich CiPSM and Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Lukowski R; Center for Integrated Protein Science Munich CiPSM and Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Seeliger MW; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy.
  • Michalakis S; Division of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
  • Wissinger B; Center for Integrated Protein Science Munich CiPSM and Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Ruth P; Molecular Genetics Laboratory, Institute for Ophthalmic Research, and.
J Clin Invest ; 128(12): 5663-5675, 2018 12 03.
Article in En | MEDLINE | ID: mdl-30418171
ABSTRACT
Mutations in CNGA3 and CNGB3, the genes encoding the subunits of the tetrameric cone photoreceptor cyclic nucleotide-gated ion channel, cause achromatopsia, a congenital retinal disorder characterized by loss of cone function. However, a small number of patients carrying the CNGB3/c.1208G>A;p.R403Q mutation present with a variable retinal phenotype ranging from complete and incomplete achromatopsia to moderate cone dysfunction or progressive cone dystrophy. By exploring a large patient cohort and published cases, we identified 16 unrelated individuals who were homozygous or (compound-)heterozygous for the CNGB3/c.1208G>A;p.R403Q mutation. In-depth genetic and clinical analysis revealed a co-occurrence of a mutant CNGA3 allele in a high proportion of these patients (10 of 16), likely contributing to the disease phenotype. To verify these findings, we generated a Cngb3R403Q/R403Q mouse model, which was crossbred with Cnga3-deficient (Cnga3-/-) mice to obtain triallelic Cnga3+/- Cngb3R403Q/R403Q mutants. As in human subjects, there was a striking genotype-phenotype correlation, since the presence of 1 Cnga3-null allele exacerbated the cone dystrophy phenotype in Cngb3R403Q/R403Q mice. These findings strongly suggest a digenic and triallelic inheritance pattern in a subset of patients with achromatopsia/severe cone dystrophy linked to the CNGB3/p.R403Q mutation, with important implications for diagnosis, prognosis, and genetic counseling.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Ion Channel Gating / Color Vision Defects / Retinal Cone Photoreceptor Cells / Mutation, Missense / Cyclic Nucleotide-Gated Cation Channels / Heterozygote Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Ion Channel Gating / Color Vision Defects / Retinal Cone Photoreceptor Cells / Mutation, Missense / Cyclic Nucleotide-Gated Cation Channels / Heterozygote Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2018 Document type: Article
...